000			03070nam a22003618i 4500
001			CR9780511663512
003			UkCbUP
005			20200124160244.0
006			m|||||o||d||||||||
007			cr||||||||||||
008			091216s1996||||enk o ||1 0|eng|d
020			_a9780511663512 (ebook)
020			_z9780521471763 (hardback)
040			_aUkCbUP _beng _erda _cUkCbUP
050	0	0	_aRG580.C3 _bC355 1996
082	0	0	_a618.3 _220
245	0	0	_aCancer in pregnancy : _bmaternal and fetal risks / _cedited by G. Koren, M. Lishner, D. Farine.
264		1	_aCambridge : _bCambridge University Press, _c1996.
300			_a1 online resource (xii, 221 pages) : _bdigital, PDF file(s).
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
505	0		_a1. Cancer in pregnancy: identification of unanswered questions on maternal and fetal risks / G. Koren, M. Lishner and D. Zemlickis -- 2. The pregnant patient with malignant disease: maternal-fetal conflict / D. Farine and E.N. Kelly -- 3. Changes in drug disposition during pregnancy and their clinical implications / G. Koren -- 4. The role of the placenta in the biotransformation of carcinogenic compounds / L. Derewlany and G. Koren -- 5. Antepartum fetal monitoring in the oncologic patient / Y. Ezra and K. Panter -- 6. The Toronto Study Group: methodological notes / G. Koren, D. Zemlickis and M. Lishner -- 7. Motherisk: the process of counselling in reproductive toxicology / G. Koren and A. Pastuszak -- 8. Maternal and fetal outcome following breast cancer in pregnancy / D. Zemlickis, M. Lishner, P. Degendorfer, T. Panzarella, S.B. Sutcliffe and G. Koren.
520			_aCancer in pregnancy, although thankfully a relatively uncommon occurrence, presents physicians and their patients with a major dilemma. The urge to use the highest tolerable doses of chemotherapy, high doses of irradiation and surgery has to be weighed carefully against their risks to the unborn baby. This book is the very first to attempt to quantify these risks and provide physicians with a core of knowledge that will be very relevant to making sound clinical decisions in the face of sometimes conflicting interests. The volume evaluates the results of the Motherisk Program, which was set up specifically to address this problem, and reviews maternal and fetal outcomes from a sizeable database of the most common cases of cancer in pregnancy. In reviewing this program and the experience of others in this area, this volume sets out to create a clinically relevant tool for oncologists, obstetrician-gynecologists, perinatologists and neonatologists.
650		0	_aCancer in pregnancy.
650		0	_aFetus _xEffect of drugs on.
700	1		_aKoren, Gideon, _d1947- _eeditor.
700	1		_aLishner, M. _q(Michael), _eeditor.
700	1		_aFarine, D. _q(Dan), _eeditor.
776	0	8	_iPrint version: _z9780521471763
856	4	0	_uhttps://doi.org/10.1017/CBO9780511663512
999			_c518801 _d518799